RGEN Q1 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$76M+25.5% YoY

Gross Profit

$44M58.0% margin

Operating Income

$12M15.6% margin

Net Income

$10M12.9% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$337M

Stockholders' Equity

$1.1B

Cash & Equivalents

$530M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$61M	+25.5%
Gross Profit	$44M	$34M	+30.5%
Operating Income	$12M	$11M	+6.6%
Net Income	$10M	$8M	+21.9%

Revenue Segments

Product

$76M100%

Royalty

$30,0000%